| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 1.48 | 0.94 | 6.06 | 10.47 |
| Other Net | 0.78 | 0.18 | 0.18 | 0.21 |
| Diluted Weighted Average Shares | 7.58 | 7.58 | 7.58 | 7.58 |
| Depreciation/ Amortization | 0.09 | 0.09 | 4.95 | 9.92 |
| Operating Income | -1.22 | -0.71 | -6.00 | -10.39 |
| Net Income | -0.68 | -0.66 | -6.01 | -10.40 |
| Income Availableto Com Excl Extra Ord | -0.68 | -0.66 | -6.01 | -10.40 |
| Net Income Before Taxes | -0.68 | -0.66 | -6.01 | -10.40 |
| Other Operating Expenses Total | 1.08 | 0.54 | 0.74 | 0.31 |
| Net Income After Taxes | -0.68 | -0.66 | -6.01 | -10.40 |
| Income Availableto Com Incl Extra Ord | -0.68 | -0.66 | -6.01 | -10.40 |
| Costof Revenue Total | 0.00 | 0.00 | 0.07 | -0.05 |
| Gross Profit | 0.26 | 0.23 | -0.01 | 0.13 |
| Interest Inc( Exp) Net- Non- Op Total | -0.24 | -0.13 | -0.18 | -0.23 |
| Diluted Net Income | -0.68 | -0.66 | -6.01 | -10.40 |
| Provisionfor Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | -0.68 | -0.66 | -6.01 | -10.40 |
| Total Revenue | 0.26 | 0.23 | 0.06 | 0.09 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 0.26 | 0.23 | 0.06 | 0.09 |
| Selling/ General/ Admin Expenses Total | 0.31 | 0.31 | 0.30 | 0.29 |
| Diluted Normalized EPS | -0.09 | -0.09 | -0.79 | -1.37 |
| Diluted EPS Excluding Extra Ord Items | -0.09 | -0.09 | -0.79 | -1.37 |
| Unusual Expense( Income) | - | 0.00 | - | - |
| Gain( Loss)on Saleof Assets | - | - | 0.00 | 0.00 |
Transgene Biotek Dividend Transgene Biotek Bonus Transgene Biotek News Transgene Biotek AGM Transgene Biotek Rights Transgene Biotek Splits Transgene Biotek Board Meetings Transgene Biotek Key Metrics Transgene Biotek Shareholdings Transgene Biotek Balance Sheet Transgene Biotek Cashflow Transgene Biotek Q1 Results Transgene Biotek Q2 Results Transgene Biotek Q3 Results Transgene Biotek Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks